PFND OTC
Pathfinder Cell Therapy, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -94.4%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
-100.0% ▼
Operating Income
-$1M
+30.0% ▲
Net Income
-$2M
+7.8% ▲
EPS (Diluted)
$-0.00
+7.4% ▲
EBITDA
-$1M
+29.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 |
|---|---|---|---|---|---|
| Revenue | $344K | $73K | $114K | $54K | $0 |
| YoY Growth | -4.4% | -78.8% | +56.2% | -52.6% | -100.0% |
| Cost of Revenue | $92K | $26K | $50K | $37K | $0 |
| Gross Profit | $252K | $47K | $64K | $17K | $0 |
| Gross Margin | 73.3% | 64.4% | 56.1% | 31.5% | — |
| R&D Expenses | $728K | $2M | $1M | $672K | $262K |
| SG&A Expenses | $2M | $2M | $796K | $944K | $857K |
| Operating Expenses | $3M | $4M | $2M | $2M | $1M |
| Operating Income | -$2M | $4M | -$2M | -$2M | -$1M |
| Operating Margin | -726.5% | 5378.1% | -1807.0% | -2961.1% | — |
| Interest Expense | $12K | $108K | $96K | $195K | $0 |
| Income Before Tax | -$3M | -$11M | -$2M | -$2M | -$1M |
| Tax Expense | -$433K | $8M | $96K | $106K | $0 |
| Net Income | -$2M | -$19M | -$2M | -$2M | -$2M |
| Net Margin | -603.5% | -25920.5% | -1975.4% | -3353.7% | — |
| EPS (Diluted) | $-0.00 | $-0.04 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$2M | -$4M | -$2M | -$2M | -$1M |
| Shares Outstanding | 458M | 526M | 667M | 667M | 667M |